Genome-wide linkage and association analyses implicate FASN in predisposition to uterine leiomyomata

American Journal of Human Genetics

Volumn 91, Issue 4, 2012, Pages 621-628

  Eggert, Stacey L ^a   Huyck, Karen L ^c   Somasundaram, Priya ^b   Kavalla, Raghava ^b   Stewart, Elizabeth A ^d   Lu, Ake T ^e   Painter, Jodie N ^f   Montgomery, Grant W ^f   Medland, Sarah E ^f   Nyholt, Dale R ^f   Treloar, Susan A ^f,g   Zondervan, Krina T ^h   Heath, Andrew C ⁱ   Madden, Pamela A F ⁱ   Rose, Lynda ^b   Buring, Julie E ^a,b   Ridker, Paul M ^a,b   Chasman, Daniel I ^a,b   Martin, Nicholas G ^f   Cantor, Rita M ^e   Morton, Cynthia C ^a,b   more..

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^d MAYO CLINIC COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^g UNIVERSITY OF QUEENSLAND   (Australia)

^h UNIVERSITY OF OXFORD   (United Kingdom)

ⁱ WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; CELL SURVIVAL; CHROMOSOME 10P; CHROMOSOME 11P; CHROMOSOME 12Q; CHROMOSOME 17Q; CHROMOSOME 2Q; CHROMOSOME 5P; COILED COIL DOMAIN CONTAINING 57 GENE; CONTROLLED STUDY; FATTY ACID SYNTHASE GENE; FEMALE; GENE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOME; GENOTYPE; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MYOMETRIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM; SOLUTE-CARRIER FAMILY 16 MEMBER 3 GENE; TISSUE MICROARRAY; UPREGULATION; UTERINE LEIOMYOMATA; UTERUS MYOMA;

ALLELES; COHORT STUDIES; FATTY ACID SYNTHASE, TYPE I; FEMALE; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; HUMANS; HYSTERECTOMY; LEIOMYOMA; LINKAGE DISEQUILIBRIUM; LOD SCORE; MONOCARBOXYLIC ACID TRANSPORTERS; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, MESSENGER; SIBLINGS; UTERINE NEOPLASMS;

EID: 84867244386     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.08.009     Document Type: Article

References (40)

1. S.F. Cramer, and A. Patel The frequency of uterine leiomyomas Am. J. Clin. Pathol. 94 1990 435 438
2. V.C. Buttram Jr., and R.C. Reiter Uterine leiomyomata: Etiology, symptomatology, and management Fertil. Steril. 36 1981 433 445
3. L.A. Lepine, S.D. Hillis, P.A. Marchbanks, L.M. Koonin, B. Morrow, B.A. Kieke, and L.S. Wilcox Hysterectomy surveillance - United States, 1980-1993 MMWR CDC Surveill. Summ. 46 1997 1 15
4. M. Flynn, M. Jamison, S. Datta, and E. Myers Health care resource use for uterine fibroid tumors in the United States Am. J. Obstet. Gynecol. 195 2006 955 964
5. M.S. Rein, A.J. Friedman, R.L. Barbieri, K. Pavelka, J.A. Fletcher, and C.C. Morton Cytogenetic abnormalities in uterine leiomyomata Obstet. Gynecol. 77 1991 923 926
6. K.L. Gross, and C.C. Morton Genetics and the development of fibroids Clin. Obstet. Gynecol. 44 2001 335 349
7. I. Brosens, J. Deprest, P. Dal Cin, and H. Van den Berghe Clinical significance of cytogenetic abnormalities in uterine myomas Fertil. Steril. 69 1998 232 235
8. N.C. Christacos, B.J. Quade, P. Dal Cin, and C.C. Morton Uterine leiomyomata with deletions of Ip represent a distinct cytogenetic subgroup associated with unusual histologic features Genes Chromosomes Cancer 45 2006 304 312
9. K.L. Huyck, C.I. Panhuysen, K.T. Cuenco, J. Zhang, H. Goldhammer, E.S. Jones, P. Somasundaram, A.M. Lynch, B.L. Harlow, and H. Lee The impact of race as a risk factor for symptom severity and age at diagnosis of uterine leiomyomata among affected sisters Am J Obstet Gynecol. 198 2008 168.e1 168.e9
10. L.M. Marshall, D. Spiegelman, R.L. Barbieri, M.B. Goldman, J.E. Manson, G.A. Colditz, W.C. Willett, and D.J. Hunter Variation in the incidence of uterine leiomyoma among premenopausal women by age and race Obstet. Gynecol. 90 1997 967 973
11. E.M. Vikhlyaeva, Z.S. Khodzhaeva, and N.D. Fantschenko Familial predisposition to uterine leiomyomas Int. J. Gynaecol. Obstet. 51 1995 127 131
12. S.A. Treloar, K.A. Do, and N.G. Martin Genetic influences on the age at menopause Lancet 352 1998 1084 1085
13. R. Luoto, J. Kaprio, E.M. Rutanen, P. Taipale, M. Perola, and M. Koskenvuo Heritability and risk factors of uterine fibroids - the Finnish Twin Cohort study Maturitas 37 2000 15 26
14. M. Schoenberg Fejzo, H.R. Ashar, K.S. Krauter, W.L. Powell, M.S. Rein, S. Weremowicz, S.J. Yoon, R.S. Kucherlapati, K. Chada, and C.C. Morton Translocation breakpoints upstream of the HMGIC gene in uterine leiomyomata suggest dysregulation of this gene by a mechanism different from that in lipomas Genes Chromosomes Cancer 17 1996 1 6
15. J.C. Hodge, K. T Cuenco, K.L. Huyck, P. Somasundaram, C.I. Panhuysen, E.A. Stewart, and C.C. Morton Uterine leiomyomata and decreased height: A common HMGA2 predisposition allele Hum. Genet. 125 2009 257 263
16. S. Purcell, B. Neale, K. Todd-Brown, L. Thomas, M.A. Ferreira, D. Bender, J. Maller, P. Sklar, P.I. de Bakker, M.J. Daly, and P.C. Sham PLINK: A tool set for whole-genome association and population-based linkage analyses Am. J. Hum. Genet. 81 2007 559 575
17. P.M. Ridker, D.I. Chasman, R.Y. Zee, A. Parker, L. Rose, N.R. Cook, J.E. Buring Women's Genome Health Study Working Group Rationale, design, and methodology of the Women's Genome Health Study: a genome-wide association study of more than 25,000 initially healthy american women Clin. Chem. 54 2008 249 255
18. S.E. Medland, D.R. Nyholt, J.N. Painter, B.P. McEvoy, A.F. McRae, G. Zhu, S.D. Gordon, M.A. Ferreira, M.J. Wright, and A.K. Henders Common variants in the trichohyalin gene are associated with straight hair in Europeans Am. J. Hum. Genet. 85 2009 750 755
19. J.N. Painter, C.A. Anderson, D.R. Nyholt, S. Macgregor, J. Lin, S.H. Lee, A. Lambert, Z.Z. Zhao, F. Roseman, and Q. Guo Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis Nat. Genet. 43 2011 51 54
20. S.A. Treloar, J. Wicks, D.R. Nyholt, G.W. Montgomery, M. Bahlo, V. Smith, G. Dawson, I.J. Mackay, D.E. Weeks, and S.T. Bennett Genomewide linkage study in 1,176 affected sister pair families identifies a significant susceptibility locus for endometriosis on chromosome 10q26 Am. J. Hum. Genet. 77 2005 365 376
21. S.A. Treloar, K.A. Do, V.M. O'Connor, D.T. O'Connor, M.A. Yeo, and N.G. Martin Predictors of hysterectomy: An Australian study Am. J. Obstet. Gynecol. 180 1999 945 954
22. E. Kharazmi, M. Fallah, and R. Luoto Cardiovascular diseases attributable to hysterectomy: A population-based study Acta Obstet. Gynecol. Scand. 86 2007 1476 1483
23. T. Takeda, M. Sakata, A. Isobe, A. Miyake, F. Nishimoto, Y. Ota, S. Kamiura, and T. Kimura Relationship between metabolic syndrome and uterine leiomyomas: A case-control study Gynecol. Obstet. Invest. 66 2008 14 17
24. J.A. Menendez, and R. Lupu Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis Nat. Rev. Cancer 7 2007 763 777
25. R. de Sousa Abreu, L.O. Penalva, E.M. Marcotte, and C. Vogel Global signatures of protein and mRNA expression levels Mol. Biosyst. 5 2009 1512 1526
26. P.C. Cha, A. Takahashi, N. Hosono, S.K. Low, N. Kamatani, M. Kubo, and Y. Nakamura A genome-wide association study identifies three loci associated with susceptibility to uterine fibroids Nat. Genet. 43 2011 447 450
27. T. Kusakabe, M. Maeda, N. Hoshi, T. Sugino, K. Watanabe, T. Fukuda, and T. Suzuki Fatty acid synthase is expressed mainly in adult hormone-sensitive cells or cells with high lipid metabolism and in proliferating fetal cells J. Histochem. Cytochem. 48 2000 613 622
28. D. Eberlé, B. Hegarty, P. Bossard, P. Ferré, and F. Foufelle SREBP transcription factors: Master regulators of lipid homeostasis Biochimie 86 2004 839 848
29. E. Graner, D. Tang, S. Rossi, A. Baron, T. Migita, L.J. Weinstein, M. Lechpammer, D. Huesken, J. Zimmermann, S. Signoretti, and M. Loda The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer Cancer Cell 5 2004 253 261
30. P.L. Alò, P. Visca, G. Trombetta, A. Mangoni, L. Lenti, S. Monaco, C. Botti, D.E. Serpieri, and U. Di Tondo Fatty acid synthase (FAS) predictive strength in poorly differentiated early breast carcinomas Tumori 85 1999 35 40
31. S. Rossi, E. Graner, P. Febbo, L. Weinstein, N. Bhattacharya, T. Onody, G. Bubley, S. Balk, and M. Loda Fatty acid synthase expression defines distinct molecular signatures in prostate cancer Mol. Cancer Res. 1 2003 707 715
32. S. Ogino, K. Nosho, J.A. Meyerhardt, G.J. Kirkner, A.T. Chan, T. Kawasaki, E.L. Giovannucci, M. Loda, and C.S. Fuchs Cohort study of fatty acid synthase expression and patient survival in colon cancer J. Clin. Oncol. 26 2008 5713 5720
33. H. Liu, J.Y. Liu, X. Wu, and J.T. Zhang Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker Int J Biochem Mol Biol. 1 2010 69 89
34. E.S. Pizer, C. Jackisch, F.D. Wood, G.R. Pasternack, N.E. Davidson, and F.P. Kuhajda Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells Cancer Res. 56 1996 2745 2747
35. E.S. Pizer, F.J. Chrest, J.A. DiGiuseppe, and W.F. Han Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines Cancer Res. 58 1998 4611 4615
36. T. Van de Sande, E. De Schrijver, W. Heyns, G. Verhoeven, and J.V. Swinnen Role of the phosphatidylinositol 3′-kinase/PTEN/Akt kinase pathway in the overexpression of fatty acid synthase in LNCaP prostate cancer cells Cancer Res. 62 2002 642 646
37. T. Porstmann, B. Griffiths, Y.L. Chung, O. Delpuech, J.R. Griffiths, J. Downward, and A. Schulze PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP Oncogene 24 2005 6465 6481
38. P.M. Alli, M.L. Pinn, E.M. Jaffee, J.M. McFadden, and F.P. Kuhajda Fatty acid synthase inhibitors are chemopreventive for mammary cancer in neu-N transgenic mice Oncogene 24 2005 39 46
39. R. Lupu, and J.A. Menendez Pharmacological inhibitors of Fatty Acid Synthase (FASN) - Catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr. Pharm. Biotechnol. 7 2006 483 493
40. L.M. Knowles, and J.W. Smith Genome-wide changes accompanying knockdown of fatty acid synthase in breast cancer BMC Genomics 8 2007 168